BioJapan 2026 / Regenerative Medicine JAPAN 2026 / healthTECH JAPAN 2026【Kanagawa】

Event Highlights

The Premier Bio-Industry Partnering Event in Asia — Celebrating 40 Years of Connections

BioJapan combines product and technology exhibitions, expert seminars, exhibitor presentations, and a proprietary business-matching system. First held in 1986, BioJapan celebrates its 40th anniversary in 2026 and is recognized by the organizer as the world’s longest-running biotechnology-focused exhibition. Together with Regenerative Medicine JAPAN and healthTECH JAPAN, it promotes open innovation across the life-science industry.

Event Information

• Events: BioJapan 2026, Regenerative Medicine JAPAN 2026, and healthTECH JAPAN 2026
• Date: October 7 (Wed.)–9 (Fri.), 2026
• Opening Hours: 10:00–17:00
• Venue: PACIFICO Yokohama
• Venue Facilities: Exhibition Hall, Annex Hall, and North
• Address: 1-1-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa 220-0012, Japan
• Format: In-person exhibition, seminars, exhibitor presentations, and partnering meetings
• Visitor Admission: Free with advance registration
• Online Participation: Not available for the exhibition or seminars

Exhibition, Seminars, and Partnering

• Exhibition: Companies and organizations present products, technologies, research results, services, and business assets at their booths
• Seminars: Researchers, executives, and industry specialists discuss emerging technologies and current life-science industry trends
• Exhibitor Presentations: Exhibitors introduce technologies, applications, research outcomes, and services on dedicated presentation stages
• Partnering: Participants search for companies, assets, technologies, and business needs before the event and submit meeting requests through the proprietary platform
• Meeting Location: Confirmed appointments are held in dedicated meeting rooms in the on-site partnering area
• Business Objectives: Joint research, co-development, licensing, technology transfer, service proposals, fundraising, international expansion, and commercial partnerships

BioJapan 2026

BioJapan addresses the broad industrial application of biotechnology, including drug discovery, biopharmaceuticals, diagnostics, research technologies, contract services, biomanufacturing, functional foods, agriculture, chemicals, cosmetics, energy, and environmental technologies.

• Small-molecule, mid-sized, biologic, antibody, and vaccine development
• Diagnostics, biosimilars, drug-delivery systems, and pharmaceutical ingredients
• Gene therapy, immunotherapy, genetic testing, biomarkers, and medical devices
• Research instruments, reagents, consumables, bioimaging, and bioinformatics
• Contract synthesis, contract analysis, screening, CRO, CMO, CDMO, and SMO services
• Universities, public research institutions, bio-clusters, governments, and public support organizations
• Intellectual property, legal services, venture capital, institutional investment, and financial services
• Functional foods, agriculture, forestry, fisheries, chemicals, cosmetics, energy, and environmental applications

Regenerative Medicine JAPAN 2026

Regenerative Medicine JAPAN supports research, development, manufacturing, quality control, transportation, commercialization, and clinical translation in cell-based medicine and regenerative medicine.

• Embryonic stem cells, induced pluripotent stem cells, pluripotent stem cells, somatic stem cells, and mesenchymal stem cells
• Cell-culture systems, culture substrates, incubators, media, reagents, and growth factors
• Cell-processing equipment, cell separation, cell counting, imaging, and characterization
• Three-dimensional culture, organoids, tissue engineering, and bioprinting
• Cell preservation, cryopreservation, thawing, cell banks, and cell transportation
• Gene editing, gene therapy, vectors, and genetic analysis
• Quality testing, validation, regulatory science, and manufacturing control
• Cell-processing facilities, cleanrooms, GMP and GCTP-related equipment
• CRO, CDMO, manufacturing, analytical, and development-support services

healthTECH JAPAN 2026

healthTECH JAPAN integrates digital technologies, healthcare data, and life sciences to support health management, prevention, diagnosis, treatment, patient monitoring, and drug discovery.

• Digital health and digital therapeutics
• Therapeutic applications, disease-management applications, and medication-adherence tools
• AI-assisted imaging, digital diagnostics, and remote diagnostics
• Digital biomarkers and wearable devices
• Remote patient monitoring and vital-sign sensing
• Electronic health records, patient portals, personal health records, and medical-data integration
• Real-world data, data analytics, and artificial intelligence for drug discovery
• Cloud systems, cybersecurity, and healthcare information systems
• Health management, disease prediction, prevention, and pre-symptomatic healthcare services

Organizers

• BioJapan 2026: BioJapan Organizing Committee, Japan Bioindustry Association, and JTB Communication Design, Inc.
• BioJapan Organizing Committee Chairperson: Minoru Yoshida, Chairperson of the Japan Bioindustry Association and Executive Director of RIKEN
• Regenerative Medicine JAPAN 2026: Forum for Innovative Regenerative Medicine, Japan Bioindustry Association, and JTB Communication Design, Inc.
• healthTECH JAPAN 2026: Japan Bioindustry Association and JTB Communication Design, Inc.

Free Visitor Admission

• Admission Fee: Free
• Registration: Advance visitor registration is required through the official website
• Visitor Badge: Download and print the Visitor Badge from My Page and bring it to the venue
• Exhibition Hall: Access to exhibitor booths and exhibitor presentations is included
• Seminars: Access to seminars in the Annex Hall and North is included, although advance session reservations are required
• Seminar Fee: Seminar attendance is free
• Seminar Information: Detailed seminar and presentation information is scheduled for release in August
• Online Participation: Online attendance is not available

Paid Partnering

Partnering participants can use the proprietary system before and during the event to search for companies, products, services, assets, technologies, and business needs. The system supports messages, PDF file sharing, meeting requests, and automatic scheduling, allowing participants to prepare more focused business discussions.

• Early-Bird Fee: JPY 143,000 per account through August 20, 2026
• Regular Fee: JPY 165,000 per account from August 21, 2026
• Tax: All listed partnering fees include tax
• Payment Method: Credit card only
• Account Use: One account may be used by one registered participant only
• Meeting Duration: Up to 25 minutes per appointment
• Partnering Area: Entry is limited to participants carrying a Partnering Badge
• Included Access: Exhibition, seminars, partnering system, dedicated meeting area, and Partnering Networking Party
• Meeting Requests: Appointment requests are scheduled to begin in August
• Participation Format: Partnering is primarily conducted in person

Partnering Participant Profile

Partnering participation is particularly strong among pharmaceutical companies, drug-development service providers, academic institutions, and CMO or CDMO organizations. Business development, licensing, and research and development professionals account for nearly half of partnering participants.

• Drug-Development Services: 21%
• Pharmaceutical Companies: 18%
• Academia and Research Institutes: 14%
• CMO and CDMO Organizations: 7%
• Business Development and Licensing: 28%
• Research and Development: 20%
• Management and Executives: 13%
• Sales: 11%

Exhibition Plans

• Standard Plan: 3 m × 3 m raw space at JPY 572,000 per space
• Standard Plan Includes: Three partnering accounts per space
• Startup Plan: 3 m × 2 m package booth at JPY 352,000
• Startup Plan Eligibility: Companies established within the previous 10 years
• Startup Plan Includes: Two partnering accounts per booth
• University and Technical College Plan: 3 m × 2 m raw space at JPY 198,000
• University Plan Includes: One partnering account per space
• Meeting Booth in the Partnering Area: 3.5 m × 3 m package booth at JPY 880,000 per room
• Meeting Booth Includes: Four partnering accounts per booth
• Exhibitor Application Deadline: May 29, 2026 — closed

Previous Event Results

BioJapan, Regenerative Medicine JAPAN, and healthTECH JAPAN 2025 were held at PACIFICO Yokohama and brought together life-science companies, research institutions, startups, investors, and support organizations from Japan and overseas.

• Exhibiting Companies: 1,134
• Exhibition Booths: 917
• Visitors: 22,167
• Partnering Companies: 1,568
• Partnering Participants: 3,073
• Partnering Meetings: 25,498
• Participating Countries and Regions: 39

Who Should Attend

• Research and business-development professionals from pharmaceutical and biopharmaceutical companies
• Biotechnology, drug-discovery, regenerative-medicine, and digital-health startups
• CRO, CMO, CDMO, SMO, contract-analysis, and research-support companies
• Professionals involved in cell therapy, regenerative medicine, and gene therapy
• Universities, public research institutions, hospitals, and testing organizations
• Manufacturers and distributors of research instruments, reagents, and consumables
• Medical-device, diagnostic, bioinformatics, and laboratory-technology companies
• Information-technology, artificial-intelligence, data-analysis, and healthcare-system companies
• Venture-capital firms, institutional investors, and financial organizations
• Intellectual-property, legal, regulatory, and consulting professionals
• Government agencies, local governments, bio-clusters, and industry-support organizations

Overview

Commercializing life-science research requires collaboration among research institutions, pharmaceutical companies, biotechnology startups, technology providers, contract-service organizations, investors, and healthcare stakeholders. BioJapan, Regenerative Medicine JAPAN, and healthTECH JAPAN provide opportunities to discuss research collaboration, licensing, contract manufacturing, analytical services, clinical development, international expansion, customer acquisition, and fundraising. The events allow participants to review the technologies and services needed to advance research and commercialization across biotechnology, biopharmaceuticals, cell and gene therapy, research equipment, diagnostics, and digital health.

Publication Status

• Event Dates and Venue: Published
• Visitor Registration: Open
• Partnering Registration: Open
• Partnering System: Profile registration available
• Meeting Requests: Scheduled to begin in August
• Exhibitor Applications: Closed
• Exhibitor Search: Scheduled for release in August
• Seminar and Presentation Information: Scheduled for release in August
• Floor Map: Scheduled for release in September
• Online Participation: Not available

Access to the Venue

• Minatomirai Line: Approximately five minutes on foot from Minatomirai Station
• JR and Yokohama Municipal Subway: Approximately 12 minutes on foot from Sakuragi-cho Station
• From Shin-Yokohama Station: Travel toward Sakuragi-cho or Minatomirai using the municipal subway or JR lines
• From Haneda Airport: Use an airport limousine bus or the Keikyu Line toward Yokohama
• By Car: Approximately two minutes from the Minato Mirai Ramp on the K1 Yokohane Route of the Metropolitan Expressway
• Address: 1-1-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa 220-0012, Japan

Official Links